Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

Clinical trial NCT04665739 · RECRUITING

Trial details

NCT number: NCT04665739
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Lung Neuroendocrine Tumor Functioning Lung Neuroendocrine Tumor Locally Advanced Lung Neuroendocrine Neoplasm Lung Neuroendocrine Neoplasm Lung Neuroendocrine Tumor G1 Lung Neuroendocrine Tumor G2 Metastatic Lung Neuroendocrine Neoplasm Metastatic Lung Neuroendocrine Tumor Non-Functioning Lung Neuroendocrine Tumor Recurrent Lung Neuroendocrine Neoplasm Unresectable Lung Neuroendocrine Neoplasm Unresectable Lung Neuroendocrine Tumor

Start date: 2023-02-03
Primary completion: 2027-07-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.